Search results for: “Ascribe Bio”
-
Ascribe Bio Series A financing Closes at $12M, Co-Led by Corteva & Acre
ITHACA, N.Y. — (BUSINESS WIRE) — Ascribe Bio (“Ascribe”), an innovator in natural crop protection, today announced the closing of a successful $12 million Ascribe Bio Series A financing round. The round was co-led by Corteva, through its Corteva Catalyst platform, and Acre Venture Partners. In addition, the financing included participation from new and existing…
-
Loveland Products and Ascribe Bioscience Expand Collaboration to Develop New Phytalix®-Based Solutions for US Row Crops
Loveland Products, Inc., a leader in proprietary crop input solutions under Nutrien Ag Solutions, has announced an expanded collaboration with Ascribe Bioscience to bring new Phytalix® premix solutions to the US market. Building on a successful partnership initiated in 2023, this strategic move strengthens Loveland’s biological platform, offering growers innovative crop protection tools with proven…
-
Ascribe Bio’s Phytalix® Achieves Breakthrough in Fight Against Bacterial Leaf Blight (BLB) in Rice
Ascribe, an innovator in natural crop protection, today announced results from 2024 field trials in India with Phytalix®, its flagship, non-toxic solution for disease control. The trials confirm that Phytalix provides unparalleled defense against Bacterial Leaf Blight (BLB) in rice, effectively protecting one of the world’s most important food sources and increasing yields by up…
-
Source Agriculture Corp. Makes Strategic Investment in Ascribe Bioscience to Advance Sustainable Crop Protection Solutions
Source Agriculture Corp., a leader in agri-tech investments, has announced a strategic investment in Ascribe Bioscience, an innovative company focused on developing sustainable crop protection solutions. This partnership underscores Source Agriculture’s commitment to advancing environmentally responsible and high-tech farming practices globally. Empowering Farmers with Sustainable Solutions Founded in 2017, Ascribe Bioscience is dedicated to discovering…
-
Ascribe collaborates with Corteva to advance seed treatment use for Phytalix® biofungicide
Summary: Ascribe Bio and Corteva have entered a strategic R&D collaboration to adapt Ascribe’s novel ascaroside technology for seed treatments. By expanding the use of Ascribe’s Phytalix® biofungicide from foliar to seed applications, the partners aim to protect germinating crops from early-season soil-borne pathogens and tap into an $11 billion global seed treatment market. Ascribe…
-
Ascribe Announces Collaboration with Corteva to Advance Seed Treatment Use for Phytalix® Biofungicide
Summary: Ascribe Bio and Corteva have announced a multi-year, strategic research and development collaboration to advance novel biofungicide technology for seed treatments. By adapting Ascribe’s Phytalix® ascaroside technology—currently used for foliar applications—the partners aim to protect germinating seeds from early-season fungal diseases and tap into an $11 billion global seed treatment market. Ascribe Bio and…
-
Loveland Products and Ascribe Team Up to Launch Biofungicides for U.S. Row Crops
Loveland Products, Inc., an affiliate of Nutrient Ag Solutions, Inc., and Ascribe Bioscience have entered into a joint development agreement and supply agreement. Loveland Products will commercialize two new crop protection products containing Ascribe’s biofungicide, Phytalix. This collaboration is expected to bring Phytalix-based products to the U.S. row crop market under the Loveland Products’ brand…